StockMap tracks 41 large-cap U.S. stocks in the Life Sciences Tools & Services industry. Their combined market capitalisation is $842.53B. On the most recent trading day the industry was down 3.39% on average. Its largest constituents by market capitalisation are TMO, DHR, A, WAT, IQV. Every stock in this industry carries a conviction signal and a two-week outlook, and calls that lean one way are graded in public once their window closes.
| Symbol | Name | Cap |
|---|---|---|
| TMO | Thermo Fisher Scientific | $257.71B |
| DHR | Danaher | $163.38B |
| A | Agilent Technologies | $49.30B |
| WAT | Waters | $45.46B |
| IQV | IQVIA Holdings | $44.06B |
| ILMN | Illumina | $35.63B |
| MTD | Mettler-Toledo International | $33.56B |
| WST | West Pharmaceutical Services | $28.74B |
| MEDP | Medpace Holdings | $18.24B |
| RVTY | Revvity | $17.52B |
| CRL | Charles River Laboratories International | $17.16B |
| ICLR | ICON | $15.83B |
| TEM | Tempus AI | $13.16B |
| TECH | Bio-Techne | $11.41B |
| RGEN | Repligen | $11.23B |
| AVTR | Avantor | $10.88B |
| QGEN | Qiagen N.V. Common Shares | $10.37B |
| TXG | 10x Genomics | $9.13B |
| BRKR | Bruker | $8.70B |
| BIO | Bio-Rad Laboratories | $8.07B |
| STVN | Stevanato Group S.p.A | $5.29B |
| SHC | Sotera Health Company | $5.18B |
| ADPT | Adaptive Biotechnologies | $4.25B |
| ABCL | AbCellera Biologics Inc. Common Shares | $3.97B |
| FTRE | Fortrea Holdings | $2.05B |
| MRVI | Maravai LifeSciences Holdings | $2.03B |
| BIO_B | Bio-Rad Laboratories | $1.92B |
| PSNL | Personalis | $1.71B |
| AZTA | Azenta | $1.71B |
| CYRX | CryoPort | $875.72M |
| PACB | Pacific Biosciences of California | $809.71M |
| CTKB | Cytek Biosciences | $796.80M |
| DNA | Ginkgo Bioworks Holdings | $721.25M |
| MLAB | Mesa Laboratories | $715.22M |
| TKNO | Alpha Teknova | $454.13M |
| QTRX | Quanterix | $137.39M |
| CDXS | Codexis | $130.31M |
| SEER | Seer | $93.02M |
| CSBR | Champions Oncology | $66.95M |
| HBIO | Harvard Bioscience | $40.51M |
| BNGO | Bionano Genomics | $13.54M |
The two-week call for each stock is on its stock page.
Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 2, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.